Biocan Novel DHPPi, Lyophilisate and solvent for suspension for injection
Biocan Novel DHPPi, Lyophilisate and solvent for suspension for injection
Ovlašten
- Canine distemper virus, strain CDV Bio 11/A, Live
- Canine adenovirus 2, strain CAV-2-Bio 13, Live
- Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live
- Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live
Identifikacija proizvoda
Naziv VMP-a:
Biocan Novel DHPPi, Lyophilisate and solvent for suspension for injection
Biocan Novel DHPPi vakcina A.U.V.
Način primjene:
-
Supkutano
Pojedinosti o proizvodu
Djelatna tvar i jačina:
-
Dostupno samo u English5.10log10 tissue culture infective dose 501.00Dose
-
Dostupno samo u English5.30log10 tissue culture infective dose 501.00Dose
-
Dostupno samo u English6.60log10 tissue culture infective dose 501.00Dose
-
Dostupno samo u English5.10log10 tissue culture infective dose 501.00Dose
Farmaceutski oblik:
-
Liofilizat i otapalo za suspenziju za injekciju
Withdrawal period by route of administration:
-
Supkutano
- Dog
Kod anatomsko-terapijsko-kemijske klasifikacije (ATKvet kȏd):
- QI07AD04
Status odobrenja:
-
Važeće
Dodatne informacije
Entitlement type:
-
Marketing Authorisation
Nositelj odobrenja za stavljanje u promet:
- Bioveta a.s.
Marketing authorisation date:
Mjesta proizvodnje za izdavanje serije:
- Bioveta a.s.
Odgovorno tijelo:
- National Food Chain Safety Office
Broj autorizacije:
- 3564/X/14 NÉBIH ÁTI
Datum promjene statusa odobrenja:
Broj postupka:
- CZ/V/0124/001
Dotična država članica:
-
Hrvatska
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Koliko je bila korisna ova stranica?: